Skip to content
intilaris LifeSciences
  • Home
  • Consulting
    • Clinical Development Excellence
    • Pharma Product Strategy
    • Management Consulting
    • Business Consulting
    • Quality Consulting
    • IT Consulting
      • GxP Systems Consulting Services
      • AGILE Validation in GxP Project Service
      • Computer System Validation CSV Service
  • Clinical
    • Clinical Trials
      • Digitally Enabled Clinical Trials
      • Therapeutic Area Consulting
      • Risk Management in Clinical Trials
      • Risk Based Monitoring
    • Clinical Systems
      • Digital Protocol
      • eTMF Implementation
      • CTMS Implementation
      • MDR Implementation
      • Protocol Automation
      • Agile Validation
    • TransCelerate Solutions
      • TransCelerate Digital Data Flow
      • TransCelerate DDF GxP Implementation
      • Common Protocol Template
  • Validation
    • CSV Service
    • GxP Systems
    • AGILE Validation
    • OSIsoft PI Validation
  • Blog
  • Contact
    • About us

Author: Djenan Ganic

Artificial Intelligence in Clinical Trials Planning and Design
February 22, 2018June 17, 2019

Artificial Intelligence in Clinical Trials Planning and Design

Clinical Trials by Djenan Ganic0 comments

To effectively discuss the topic of Artificial Intelligence AI in Clinical Trials Planning and Design, we need to discus what […]

Read more>>
TransCelerate Common Protocol Template: Considerations for Sponsor Adoption
November 6, 2017December 4, 2019

TransCelerate Common Protocol Template: Considerations for Sponsor Adoption

Clinical Study Protocols by Djenan Ganic0 comments

Assumption on my side is that if you are reading this article, then you probably are familiar with the TransCelerate […]

Read more>>
New Insights On ​ Optimizing Protocol Design Practice ​ To Maximize Development Performance
March 29, 2017December 4, 2019

New Insights On ​ Optimizing Protocol Design Practice ​ To Maximize Development Performance

Clinical Study Protocols by Djenan Ganic0 comments

https://youtube.com/watch?v=1bIPs84LNgs%3Frel%3D0 Part 1 of 4: Ken Getz presentation, sponsored by intilaris LifeSciences  titled ‘New Insights on ​Optimizing Protocol Design Practice […]

Read more>>
Meet ICH Quality Management Goals
February 9, 2017May 22, 2019

Meet ICH Quality Management Goals

Clinical Study Protocols by Djenan Ganic0 comments

ICH E6 (R2) provides meaningful additional guidance. In regards to improving study designs, we’d like to call your attention to […]

Read more>>
Effective use of CDISC Therapeutic Area Data Standards in the study setup
November 11, 2016May 22, 2019

Effective use of CDISC Therapeutic Area Data Standards in the study setup

Clinical Standards by Djenan Ganic0 comments

The Clinical Data Interchange Standards Consortium (CDISC) has, in recent years, released several Therapeutic Area User Guides (TAUGs) ranging from […]

Read more>>
Improving Oncology Patient Enrollment
October 6, 2016May 22, 2019

Improving Oncology Patient Enrollment

Clinical Trials by Djenan Ganic0 comments

Success of a clinical study relies to big extent on enrolling patients. Nearly 25% of cancer trials fail to enroll […]

Read more>>
Standardized Trial Protocols: Service and Toolkit for generation of trial protocols based on Transcelerate template
September 8, 2016May 22, 2019

Standardized Trial Protocols: Service and Toolkit for generation of trial protocols based on Transcelerate template

Clinical Trials by Djenan Ganic0 comments

The pharma industry is generally considered as an expensive enterprise that requires considerable investments into the R&D activities with virtually […]

Read more>>
Why some pharma companies are more successful than others in converting their research dollars into clinical trials?
August 30, 2016May 16, 2019

Why some pharma companies are more successful than others in converting their research dollars into clinical trials?

Pharma R&D by Djenan Ganic0 comments

The pharma industry is generally considered as an expensive enterprise that requires considerable investments into the R&D activities with virtually […]

Read more>>
Prevent Clinical Study Protocol Amendments
February 8, 2016June 17, 2019

Prevent Clinical Study Protocol Amendments

Clinical Study Protocols by Djenan Ganic0 comments

Protocols have become more demanding and complex and as a result more amendments arise. In fact, ‘the majority of clinical […]

Read more>>
Clinical Protocols : Improve your designs and reduce costs
February 1, 2016May 16, 2019

Clinical Protocols : Improve your designs and reduce costs

Clinical Study Protocols by Djenan Ganic0 comments

The studies executed by the Tufts Center for the Study of Drug Development (Tufts CSDD), clearly show the dependency between […]

Read more>>

Posts navigation

Older posts
Newer posts

Recent Posts

  • Why do you need a clinical data reference architecture?
  • What is your Clinical Data Strategy?
  • FDA TPP – Target Product Profile – Strategic Development Tool for Therapeutic Candidates
  • Digitalized Protocol Eligibility Criteria
  • Scaled Agile Framework SAFe in GxP Projects – How can pharma IT benefit?

Recent Comments

    Archives

    Categories

    • Clinical Development
    • Clinical IT
    • Clinical Standards
    • Clinical Study Protocols
    • Clinical Trials
    • Digital
    • GMP
    • GxP
    • Pharma R&D

    Recent Posts

    • Why do you need a clinical data reference architecture?
    • What is your Clinical Data Strategy?
    • FDA TPP – Target Product Profile – Strategic Development Tool for Therapeutic Candidates
    • Digitalized Protocol Eligibility Criteria
    • Scaled Agile Framework SAFe in GxP Projects – How can pharma IT benefit?

    Recent Comments

      Archives

      • November 2021
      • August 2021
      • February 2021
      • January 2021
      • October 2020
      • September 2020
      • June 2020
      • May 2020
      • December 2019
      • November 2019
      • July 2019
      • June 2019
      • May 2019
      • February 2019
      • October 2018
      • September 2018
      • May 2018
      • February 2018
      • November 2017
      • March 2017
      • February 2017
      • November 2016
      • October 2016
      • September 2016
      • August 2016
      • February 2016
      • October 2015
      • July 2015
      • April 2015

      Categories

      • Clinical Development
      • Clinical IT
      • Clinical Standards
      • Clinical Study Protocols
      • Clinical Trials
      • Digital
      • GMP
      • GxP
      • Pharma R&D

      Meta

      • Log in
      • Entries feed
      • Comments feed
      • WordPress.org

      intilaris logo

      Our professional practice is quality and reliability focused with a pharma-centric mindset, driven by stringency and ingenuity, and in compliance with industry regulations.

      @2022 intilaris. All rights reserved.

      Contact us

      Email: optimize@intilaris.com

      Phone: +41 79 828 4794

      intilaris LifeSciences GmbH
      Technologiepark
      Hochbergerstr. 60c
      CH-4057 Basel
      Switzerland

      No. CHE-462.063.106

      Quick links

      • About us
      • Privacy Policy
      • Digital Clinical Trials
      • Risk Management
      • Protocol Automation
      • Agile Validation
      • Computer System Validation

      Follow Us



      Follow @intilaris
      Proudly powered by WordPress | Theme: Airi by aThemes.
      • Subscribe